Ambler, PA, United States of America

Nicholas Pescatore


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicholas Pescatore

Introduction

Nicholas Pescatore is an accomplished inventor based in Ambler, PA (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of blood treatment. With a total of two patents to his name, Pescatore's work focuses on innovative methods to enhance the removal of proteins from blood, which is crucial in treating conditions such as sepsis.

Latest Patents

Pescatore's latest patents include groundbreaking methods that utilize graphene nanoplatelets and polymer-derived ceramic carbide-derived carbon. These methods are designed to effectively remove proteins, including cytokines, from blood and blood products. The techniques involve contacting the blood with a form of carbon that has high graphitic content and specific pore sizes, allowing for the efficient removal of proteins within minutes or hours. Another patent details the use of thermally expanded graphite for the same purpose, showcasing his commitment to advancing medical treatments.

Career Highlights

Nicholas Pescatore is affiliated with Drexel University, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential to improve patient outcomes in critical care settings. Pescatore's innovative approaches reflect a deep understanding of both materials science and medical needs.

Collaborations

Pescatore has collaborated with notable colleagues such as Yury Gogotsi and Vadym Mochalin. These partnerships have further enriched his research and contributed to the development of effective solutions in blood treatment.

Conclusion

Nicholas Pescatore's contributions to the field of biomedical engineering through his innovative patents demonstrate his dedication to improving healthcare. His work not only addresses critical medical challenges but also paves the way for future advancements in blood treatment technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…